Treatment of gastric cancer with peritoneal carcinomatosis by cytoreductive surgery and HIPEC: a systematic review of survival, mortality, and morbidity
RS Gill, DP AlAdra, J Nagendran… - Journal of surgical …, 2011 - Wiley Online Library
Gastric cancer with peritoneal carcinomatosis has an extremely poor prognosis, which may
be improved with cytoreductive surgery (CRS) combined with heated intraperitoneal …
be improved with cytoreductive surgery (CRS) combined with heated intraperitoneal …
[HTML][HTML] Chemotherapy for intraperitoneal use: a review of hyperthermic intraperitoneal chemotherapy and early post-operative intraperitoneal chemotherapy
MD Goodman, S McPartland, D Detelich… - Journal of …, 2016 - ncbi.nlm.nih.gov
Peritoneal spread of tumors is a major problem in cancer management. Patients develop a
marked deterioration in quality of life and shortened survival. This is in part due to bowel …
marked deterioration in quality of life and shortened survival. This is in part due to bowel …
Metastatic colorectal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up☆
Colorectal cancer (CRC) is the third most common cancer worldwide, with 1.1 million new
cases per year, and is the second leading cause of cancer death. 1 CRC occurs more …
cases per year, and is the second leading cause of cancer death. 1 CRC occurs more …
[HTML][HTML] ESMO consensus guidelines for the management of patients with metastatic colorectal cancer
E Van Cutsem, A Cervantes, R Adam, A Sobrero… - Annals of …, 2016 - Elsevier
Colorectal cancer (CRC) is one of the most common malignancies in Western countries.
Over the last 20 years, and the last decade in particular, the clinical outcome for patients with …
Over the last 20 years, and the last decade in particular, the clinical outcome for patients with …
S3-leitlinie–kolorektales karzinom
W Schmiegel, B Buchberger… - Zeitschrift für …, 2017 - thieme-connect.com
2.1 Geltungsbereich und Zweck 2.1. 1. Zielsetzung und Fragestellung Das Kolorektale
Karzinom (KRK) ist mit etwa 64 000 Neuerkrankungen und ca. 26 000 Todesfällen pro Jahr …
Karzinom (KRK) ist mit etwa 64 000 Neuerkrankungen und ca. 26 000 Todesfällen pro Jahr …
Extent of colorectal peritoneal carcinomatosis: attempt to define a threshold above which HIPEC does not offer survival benefit: a comparative study
Background The main prognostic factors after complete cytoreductive surgery (CCRS) of
colorectal peritoneal carcinomatosis (PC) followed by intraperitoneal chemotherapy (IPC) …
colorectal peritoneal carcinomatosis (PC) followed by intraperitoneal chemotherapy (IPC) …
Cytoreductive surgery and hyperthermic intraperitoneal chemoperfusion versus systemic chemotherapy alone for colorectal peritoneal carcinomatosis
BACKGROUND: Survival benefit of cytoreductive surgery combined with hyperthermic
intraperitoneal chemoperfusion was demonstrated by a prospective randomized trial for …
intraperitoneal chemoperfusion was demonstrated by a prospective randomized trial for …
The current practice of cytoreductive surgery and HIPEC for colorectal peritoneal metastases: results of a worldwide web-based survey of the Peritoneal Surface …
M Bushati, KP Rovers, A Sommariva… - European journal of …, 2018 - Elsevier
Background At present, selected patients with resectable colorectal peritoneal metastases
(CRC-PM) are increasingly treated with a combination therapy of cytoreductive surgery …
(CRC-PM) are increasingly treated with a combination therapy of cytoreductive surgery …
Regional CAR-T cell infusions for peritoneal carcinomatosis are superior to systemic delivery
SC Katz, GR Point, M Cunetta, M Thorn, P Guha… - Cancer gene …, 2016 - nature.com
Metastatic spread of colorectal cancer (CRC) to the peritoneal cavity is common and difficult
to treat, with many patients dying from malignant bowel obstruction. Chimeric antigen …
to treat, with many patients dying from malignant bowel obstruction. Chimeric antigen …
[HTML][HTML] Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy improves survival for peritoneal carcinomatosis from colorectal cancer: a systematic …
CQ Huang, Y Min, SY Wang, XJ Yang, Y Liu, B Xiong… - Oncotarget, 2017 - ncbi.nlm.nih.gov
Objectives The therapeutic efficacy of cytoreductive surgery (CRS) plus hyperthermic
intraperitoneal chemotherapy (HIPEC) for patients with peritoneal carcinomatosis (PC) from …
intraperitoneal chemotherapy (HIPEC) for patients with peritoneal carcinomatosis (PC) from …